RIM
ASND icon

RS Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

RS Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-985,849
Closed -$18.3M – 384
2016
Q1 		$18.3M Buy
985,849
+6,788
+0.7% +$121K 0.18% 188
2015
Q4 		$17.9M Sell
979,061
-1,941
-0.2% -$34K 0.16% 195
2015
Q3 		$17.4M Buy
981,002
+26,732
+3% +$520K 0.15% 195
2015
Q2 		$16.8M Buy
954,270
+298,100
+45% +$5.22M 0.14% 206
2015
Q1 		$11.4M Buy
+656,170
New +$11.9M 0.1% 231

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

RS Investment Management's ASND Position: Q2 2016 in Review

RS Investment Management sold out of Ascendis Pharma A/S (ASND) in Q2 2016, closing a stake of 985,849 shares — an estimated $18.3M sold.

RS Investment Management first reported a position in ASND in Q1 2015 and held it in 5 quarters. The position peaked at $18.3M in Q1 2016. 23 funds tracked by Wall St. Rank hold ASND as of Q2 2016.

  • RS Investment Management reported no remaining Ascendis Pharma A/S position as of Q2 2016 after selling out during the quarter.
  • RS Investment Management sold 985,849 Ascendis Pharma A/S shares in Q2 2016, an estimated $18.3M.
  • RS Investment Management first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 5 quarters.
  • RS Investment Management's Ascendis Pharma A/S position peaked at $18.3M in Q1 2016.
  • 23 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.